Although BPC-157 is not a dedicated weight loss peptide, some individuals may benefit from its potential recovery-supporting properties
We advise against use in patients with active cancer, cardiovascular disease, autoimmune disorders, liver or kidney disease, clotting issues, pregnancy or breastfeeding, or those under age 20
Hepatoprotective Effect of BPC 157, a 15-Amino Acid Peptide, on Liver Lesions Induced by Either Restraint Stress or Bile Duct and Hepatic Artery Ligation or CCl4 Administration
A larger phase IIb trial of intranasal glutathione (300 mg/dose, three times daily for 3 months, n=45) also showed no significant improvement over placebo (Mischley et al., J Parkinsons Dis, 2017) [52]